Abstract

Ischemic preconditioning (IPC) significantly reduces ischemia–reperfusion injury in the brain by inducing ischemic tolerance. Although emerging evidence suggests that microRNAs (miRNAs) contribute to the pathogenesis of brain ischemia and IPC-induced neuroprotection, the role of miRNAs and their underlying mechanisms are still unclear. IPC was induced in male C57BL/6 mice by brief bilateral common carotid artery occlusion. After 24 h, mice underwent transient middle cerebral artery occlusion followed by 3 h of reperfusion. Expression levels of messenger RNAs (mRNAs) and proteins were examined in the ipsilateral cortex, and mimics and inhibitors of selective miRNAs were transfected into Neuro-2a cells before oxygen–glucose deprivation (OGD). Post-IPC miRNA expression profiling identified neuroprotection-associated changes in miRNA expression in the ipsilateral cortex after ischemic stroke. Among them, miR-33-5p and miR-135b-5p were significantly downregulated by IPC. Inhibition of miR-33-5p and miR-135b-5p expression protected Neuro-2a cells from OGD-induced apoptosis. Inhibition of these two miRNAs significantly increased mRNA and protein levels of ATP-binding cassette subfamily A member 1 (ABCA1), and a binding assay showed that these two miRNAs showed specificity for Abca1 mRNA. Overexpression of ABCA1 decreased the Bax/Bcl2 mRNA ratio and activation of caspase-9 and caspase-3, whereas knockdown of ABCA1 expression increased the Bax/Bcl2 mRNA ratio and the percentage of Neuro-2a cells with a loss of mitochondrial membrane potential after OGD-treatment. In conclusion, ABCA1 expression is regulated by miR-33-5p and miR-135b-5p. Increased ABCA1 expression following IPC exerts a protective influence against cerebral ischemia via suppression of a mitochondria-dependent apoptosis pathway.

Highlights

  • Ischemic preconditioning (IPC) significantly reduces ischemia–reperfusion injury in the brain by inducing ischemic tolerance

  • We previously reported ischemic protection of the bilateral common carotid artery occlusion (BCCAO) IPC paradigm by showing a smaller infarct volume (~ 48%) in the IPC + middle cerebral artery occlusion (MCAO) group compared to the control and sham + MCAO groups

  • We used RT-qPCR to compare the expression of apoptosis-promoting Bax messenger RNAs (mRNAs) and apoptosis-inhibiting Bcl[2] mRNA in the IPC + MCAO group (n = 6) to their expressions in the control group (n = 6) and the sham + MCAO group (n = 6)

Read more

Summary

Introduction

Ischemic preconditioning (IPC) significantly reduces ischemia–reperfusion injury in the brain by inducing ischemic tolerance. Emerging evidence suggests that microRNAs (miRNAs) contribute to the pathogenesis of brain ischemia and IPC-induced neuroprotection, the role of miRNAs and their underlying mechanisms are still unclear. Inhibition of miR-33-5p and miR-135b-5p expression protected Neuro-2a cells from OGD-induced apoptosis Inhibition of these two miRNAs significantly increased mRNA and protein levels of ATPbinding cassette subfamily A member 1 (ABCA1), and a binding assay showed that these two miRNAs showed specificity for Abca[1] mRNA. Emerging evidence shows that miRNAs contribute to the pathogenesis of brain ischemia and the neuroprotection induced by IPC by acting as both negative and positive regulators of cell s­ urvival[5,6]. Recent studies have documented changes in miRNA expression profiles in response to ischemia using both experimental cerebral ischemia and/or IPC models, suggesting that miRNA-mediated post-transcriptional inhibition may be important for regulating gene expression under. Due to different experimental designs, different IPC stimuli, and diverse in vivo and in vitro models, the complexity of IPC-induced neuroprotection through miRNAs and their targets makes it difficult to understand the extent of their contributions

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call